Acquired Immunodeficiency Syndrome

• 

  Subject Areas on Research

  • "A Survey of Beliefs about Managed Care" 
  • "Getting to Zero" Among Men Who Have Sex with Men in China: a Review of the HIV Care Continuum. 
  • "The education-knowledge road to Health for All--strategy for the 1990's". 
  • 12 myths about HIV/AIDS and people who use drugs. 
  • 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. 
  • A COVID-19 conference at AIDS 2020: Virtual. 
  • A brief assessment of learning for orphaned and abandoned children in low and middle income countries. 
  • A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. 
  • A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. 
  • A framework for revising preservice curriculum for nonphysician clinicians: The mozambique experience. 
  • A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. 
  • A new and timely delusion: the complaint of having AIDS. 
  • A pandemic anniversary: 40 years of HIV/AIDS. 
  • A randomized controlled trial of a coping group intervention for adults with HIV who are AIDS bereaved: longitudinal effects on grief. 
  • A randomized controlled trial of health information exchange between human immunodeficiency virus institutions. 
  • A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team. 
  • A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. 
  • A surgical oncology perspective on AIDS. 
  • A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. 
  • AIDS 1990. Vaccines and immunology: overview. 
  • AIDS 2016: from aspiration to implementation. 
  • AIDS and HIV infection. 
  • AIDS and global justice. 
  • AIDS and public policy: the lessons and challenges of "success" in Thailand. 
  • AIDS and the dermatologist. A perspective. 
  • AIDS exceptionalism. 
  • AIDS exceptionalism. 
  • AIDS is your business. 
  • AIDS response. 
  • AIDS vaccines. 
  • AIDS vaccines: progress and unmet challenges. 
  • AIDS-associated Kaposi's sarcoma: variables associated with survival. 
  • AIDS-associated diarrhea and wasting in Northeast Brazil is associated with subtherapeutic plasma levels of antiretroviral medications and with both bovine and human subtypes of Cryptosporidium parvum. 
  • AIDS-related malignancies. 
  • AIDS-related stigma, HIV testing, and transmission risk among patrons of informal drinking places in Cape Town, South Africa. 
  • AIDS. Do antibodies enhance the infection of cells by HIV? 
  • AIDS. Where has HIV been hiding? 
  • AIDS/HIV. Host controls of HIV neutralizing antibodies. 
  • Abstracts of AIDS Vaccine 2009. Paris, France. October 19-22, 2009. 
  • Accounting for institutional change in health economic evaluation: a program to tackle HIV/AIDS and gender violence in Southern Africa. 
  • Acquired immunodeficiency syndrome (AIDS). 
  • Acquired immunodeficiency syndrome-like illness associated with systemic Mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man. 
  • Activation of tat-defective human immunodeficiency virus by ultraviolet light. 
  • Active cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir). 
  • Acute retinal necrosis after chickenpox in a patient with acquired immunodeficiency syndrome. 
  • Addressing the Know-Do Gap in Adolescent HIV: Framing and Measuring Implementation Determinants, Outcomes, and Strategies in the AHISA Network. 
  • Addressing the challenges of adherence. 
  • Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in North Carolina. 
  • Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. 
  • Africa and AIDS: still much work to be done. 
  • Allocating HIV-prevention resources: balancing efficiency and equity. 
  • Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. 
  • Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. 
  • An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. 
  • Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES. 
  • Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents. 
  • Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs. 
  • Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. 
  • Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. 
  • Anti-idiotypic antibodies as vaccine candidates. The immune network. 
  • Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. 
  • Antifungal prophylaxis: to prevent or not. 
  • Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development. 
  • Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. 
  • Approaches to HIV vaccine design. 
  • Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. 
  • Assessing stigma in low- and middle-income countries: A systematic review of scales used with children and adolescents. 
  • Assessing the effects of anti-homosexuality legislation in Uganda on HIV prevention, treatment, and care services. 
  • Assessing the magnitude of the HIV/AIDS epidemic in Burma. 
  • Barrier protection against the human immunodeficiency virus. 
  • Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. 
  • Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus. 
  • Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. 
  • CCL3L1 and HIV/AIDS susceptibility. 
  • CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time. 
  • Case 9-1989: AIDS and a cavitary pulmonary lesion. 
  • Cellular immune response to viral peptides in patients exposed to HIV. 
  • Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection. 
  • Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. 
  • Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. 
  • Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. 
  • Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. 
  • Choroidal lesions in patients with AIDS. 
  • Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex. 
  • Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U). 
  • Community-based voluntary counseling and testing services in rural communities of Chiang Mai Province, Northern Thailand. 
  • Comorbidity of depression with other medical diseases in the elderly. 
  • Comparative hybridization reveals extensive genome variation in the AIDS-associated pathogen Cryptococcus neoformans. 
  • Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. 
  • Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). 
  • Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. 
  • Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. 
  • Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. 
  • Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. 
  • Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. 
  • Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use. 
  • Cost effectiveness analysis of early zidovudine treatment of HIV infected patients. 
  • Country ownership and the turning point for HIV/AIDS. 
  • Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. 
  • Cryptococcosis. 
  • Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal. 
  • Cryptococcus neoformans Chitin Synthase 3 Plays a Critical Role in Dampening Host Inflammatory Responses. 
  • Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). 
  • Cutaneous cryptococcosis and histoplasmosis coinfection in a patient with AIDS. 
  • Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). 
  • DNA polymerases versus HIV reverse transcriptase in AIDS therapy. 
  • Definitions of implementation science in HIV/AIDS. 
  • Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group. 
  • Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115. 
  • Depression, suicidality, and alcohol use disorder among people living with HIV/AIDS in Nigeria. 
  • Depressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: a prospective, observational study. 
  • Detection of mucosal antibodies in HIV type 1-infected individuals. 
  • Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. 
  • Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. 
  • Development of a novel screen for protease inhibitors. 
  • Development of a vaccine for the prevention of AIDS, a critical appraisal. 
  • Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316. 
  • Diagnosis and screening of HIV/AIDS using clinical criteria in Tanzanian adults. 
  • Did AIDS mortality decrease the number of lifetime sexual partners in Kenya: an ecological analysis? 
  • Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). 
  • Disease drivers of aging. 
  • Distributing US health aid. 
  • Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. 
  • Does access to health care impact survival time after diagnosis of AIDS? 
  • Drug use and HIV/AIDS in Burma. 
  • Early zidovudine and survival in HIV infection. 
  • Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit. 
  • Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. 
  • Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study. 
  • Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. 
  • Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. 
  • Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon. 
  • Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. 
  • Engagement of Gay Men and Other Men Who Have Sex with Men (MSM) in the Response to HIV: A Critical Step in Achieving an AIDS-Free Generation. 
  • Engaging men in prevention and care for HIV/AIDS in Africa. 
  • Enhanced HIV-1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24. 
  • Enteroinvasive Escherichia coli: a cause of bacteremia in patients with AIDS. 
  • Epidemiology of tuberculosis in North Carolina, 1966 to 1986: analysis of demographic features, geographic variation, AIDS, migrant workers, and site of infection. 
  • Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. 
  • Estimating the parameters in the Cox model when covariate variables are measured with error. 
  • Ethical dilemmas in continuing a zidovudine trial after early termination of similar trials. 
  • Evaluating marker-guided treatment selection strategies. 
  • Evaluation of an atypical HIV type 1 antibody. Serologic pattern leading to detection of HIV type 2 infection in North America. 
  • Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases. 
  • Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. 
  • Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome. 
  • Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959. 
  • Extent of surgical intervention in primary soft-tissue aspergillosis. 
  • FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. 
  • Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. 
  • Failure to thrive, diarrhea, cough, and oral candidiasis in a three-month-old boy. 
  • Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. 
  • Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. 
  • Gender differences in heterosexual anal sex practices among women and men in substance abuse treatment. 
  • Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. 
  • Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA [corrected]. 
  • Genetic typing of HIV-2 from a Senegalese/German heterosexual transmission. 
  • George Bush, Michael Dukakis, and health policy issues in the 1988 presidential campaign. 
  • Global AIDS prevention and control. 
  • Global dimensions of the AIDS epidemic: implications for prevention and care. 
  • Global estimates and epidemiology of HIV-1 infections and AIDS: further heterogeneity in spread and impact. 
  • Governance for health: the HIV response and general global health. 
  • Government-NGO collaboration and sustainability of orphans and vulnerable children projects in southern Africa. 
  • Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. 
  • Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice. 
  • Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. 
  • Guidelines for treatment of skin diseases in children with HIV infection. 
  • HIV Diagnoses, Prevalence and Outcomes in Nine Southern States. 
  • HIV Infection and AIDS in the Deep South. 
  • HIV and women in the USA: what we know and where to go from here. 
  • HIV disinformation. 
  • HIV disorders of the brain: pathology and pathogenesis. 
  • HIV epidemiology update and transmission factors: risks and risk contexts--16th International AIDS Conference epidemiology plenary. 
  • HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study. 
  • HIV infection in children. 
  • HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. 
  • HIV prevalence, sexual and behavioral correlates among Shan, Hill tribe, and Thai male sex workers in Northern Thailand. 
  • HIV therapeutics: an emerging science. 
  • HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. 
  • HIV-1 fitness and macrophages. 
  • HIV-1 sensitivity to zidovudine and clinical outcome in children. 
  • HIV-1-associated thrombocytopenia. The role of splenectomy. 
  • HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. 
  • HIV-2-associated AIDS in the United States. The first case. 
  • HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults. 
  • HIV/AIDS knowledge, attitudes, and practices among Burmese migrant factory workers in Tak Province, Thailand. 
  • HPV-16-related DNA sequences in Kaposi's sarcoma. 
  • HTLV-III seroconversion associated with heat-treated factor VIII concentrate. 
  • Health education: historic windows of opportunity. 
  • Health education: historic windows of opportunity. 
  • Helminthic infections in the acquired immunodeficiency syndrome. 
  • Hepatitis B surface antigen could harbour the infective agent of AIDS. 
  • Herpes simplex keratitis in patients with acquired immune deficiency syndrome. 
  • High rates of AIDS-related mortality among older adults in rural Kenya. 
  • High throughput functional analysis of HIV-1 env genes without cloning. 
  • Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. 
  • Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. 
  • Highly stressed: stressful and traumatic experiences among individuals with HIV/AIDS in the Deep South. 
  • Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma. 
  • Histology of early lesions of AIDS-associated Kaposi's sarcoma. 
  • History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke. 
  • Hospice education about people with AIDS as terminally ill patients: coping with a new epidemic of death. 
  • Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection. 
  • Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. 
  • Human immunodeficiency virus infection in childhood: the disease and its cutaneous manifestations. 
  • Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group. 
  • Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. 
  • Human immunodeficiency virus vaccines. 
  • Human immunodeficiency virus-1 disease progression in hemophiliacs. 
  • Hyponatremia in pediatric patients with HIV-1 infection. 
  • Identifying subtypes of HIV/AIDS-related symptoms in China using latent profile analysis and symptom networks. 
  • Idiopathic CD4+ T-lymphocytopenia. 
  • Immune deficiency presenting as disseminated sporotrichosis. 
  • Immunobiology of the human immunodeficiency virus envelope and its relationship to vaccine strategies. 
  • Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report. 
  • Immunodeficiency diseases. 
  • Immunodeficiency diseases. 
  • Immunodeficiency. 
  • Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians. 
  • Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. 
  • Impact of an educational programme on reproductive health among young migrant female workers in Shenzhen, China: an intervention study. 
  • Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. 
  • Impaired bone marrow in AIDS. 
  • Importance of neutralization sieve analyses when seeking correlates of HIV-1 vaccine efficacy. 
  • Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout. 
  • Improvement of HAART in Brazil, 1998-2008: a nationwide assessment of survival times after AIDS diagnosis among men who have sex with men. 
  • Improving efficiency of inferences in randomized clinical trials using auxiliary covariates. 
  • In memoriam: Joep Lange MD, PhD. 
  • In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome. 
  • In-home mental health treatment for individuals with HIV. 
  • Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts < 100/mm3. Multicenter AIDS Cohort Study. 
  • Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States. 
  • Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. 
  • Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children. 
  • Individual and Partner-Level Factors Associated with Condom Non-Use Among African American STI Clinic Attendees in the Deep South: An Event-Level Analysis. 
  • Inequalities in HAART uptake and differential survival according to exposure category in Rio de Janeiro, Brazil. 
  • Influence of HIV-1 infection and cigarette smoking on leukocyte profile in homosexual men. 
  • Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. 
  • Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. 
  • Influencing medication adherence among women with AIDS. 
  • Informing the 2011 UN Session on Noncommunicable Diseases: applying lessons from the AIDS response. 
  • Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). 
  • Interleukin-2 immunotherapy of murine cytomegalovirus retinitis during MAIDS correlates with increased intraocular CD8+ T-cell infiltration. 
  • Interleukin-8-mediated heterologous receptor internalization provides resistance to HIV-1 infectivity. Role of signal strength and receptor desensitization. 
  • Interpretation of western blots of specimens from children infected with human immunodeficiency virus type 1: implications for prognosis and diagnosis. 
  • Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. 
  • Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies. 
  • Isolation, structure determination, and anti-HIV evaluation of tigliane-type diterpenes and biflavonoid from Stellera chamaejasme. 
  • It's the patient, stupid! 
  • Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. 
  • Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome. 
  • Kaposi's sarcoma mimicking cellulitis. 
  • Kaposi's sarcoma. 
  • Knowledge and attitudes about AIDS among Canadian nursing students: educational implications. 
  • Lack of genetic differentiation between two geographically diverse samples of Candida albicans isolated from patients infected with human immunodeficiency virus. 
  • Linguistic and Cultural Adaptation of a Computer-Based Counseling Program (CARE+ Spanish) to Support HIV Treatment Adherence and Risk Reduction for People Living With HIV/AIDS: A Randomized Controlled Trial. 
  • Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment. 
  • Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines. 
  • Longitudinal effects of SafeTalk, a motivational interviewing-based program to improve safer sex practices among people living with HIV/AIDS. 
  • Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230. 
  • Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings. 
  • Loss to follow-up effect in investigations of HIV-1 incidence. 
  • Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. 
  • Lower extremity lymphedema caused by acquired immune deficiency syndrome-related Kaposi's sarcoma: case report and review of the literature. 
  • Lower likelihood of cardiac procedures after acute coronary syndrome in patients with human immunodeficiency virus/acquired immunodeficiency syndrome. 
  • Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV Heterosexual Transmission Study. 
  • Lymphoma in the immunocompromised patient. 
  • Making AIDS prevention a national priority. 
  • Management of human immunodeficiency virus-associated thrombocytopenia with intravenous gamma globulin. 
  • Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. 
  • Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. 
  • Migration of persons with AIDS--a search for support from elderly parents? 
  • Mike's treatment. 
  • Mission now possible for AIDS fund. 
  • Mood disorders in the medically ill: scientific review and recommendations. 
  • More than a Mite Contagious: Crusted Scabies. 
  • Mucocutaneous disease in pediatric human immunodeficiency virus infection. 
  • Mucosal co-infections and HIV-1 transmission and pathogenesis. 
  • Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response. 
  • Mycobacteria in stool specimens: the nonvalue of smears for predicting culture results. 
  • Mycobacterial disease in AIDS. 
  • Mycobacterial esophagitis in AIDS. 
  • Mycobacterium avium-intracellulare complex infections in the acquired immunodeficiency syndrome. 
  • Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy. 
  • Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. 
  • Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus. 
  • Negotiating risk: knowledge and use of HIV prevention by persons with serious mental illness living in supportive housing. 
  • Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection. 
  • Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. 
  • New Hampshire: the premarital testing debacle. 
  • New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1. 
  • New frontiers of immunotherapy for HIV. 
  • New insights into the role of host cell proteins in antiviral vaccine protection. 
  • Non-Hodgkin's lymphoma in the acquired immunodeficiency syndrome. 
  • Nosocomial infection rate as a function of human immunodeficiency virus type 1 status in hemophiliacs. 
  • Nurses, Nurse-Led Interventions, and Nursing Models of Care: Essential in HIV Prevention, Care, and Treatment. 
  • Ocular effects in acquired immune deficiency syndrome. 
  • Ocular toxoplasmosis in AIDS patients. 
  • Oligoclonal banding detected by urinary protein electrophoresis and immunofixation in two patients with the acquired immune deficiency syndrome and proteinuria. 
  • On being poor with HIV. 
  • Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. 
  • Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy. 
  • Outcomes from a group intervention for coping with HIV/AIDS and childhood sexual abuse: reductions in traumatic stress. 
  • Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. 
  • Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission? 
  • Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose. 
  • Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. 
  • Pathogenesis and natural history of HIV infection. 
  • Patterns of HIV and syphilis infection in Northern Thailand 1998-2001. 
  • Pediatric AIDS prognosis using somatic growth velocity. 
  • Pediatric HIV infection. An update. 
  • Pediatric acquired immunodeficiency syndrome. Barriers to recognizing the role of child sexual abuse. 
  • Pediatric human immunodeficiency virus infection and its cutaneous manifestations. 
  • Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi. 
  • Pericardial effusion in AIDS. 
  • Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. 
  • Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction. 
  • Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. 
  • Pharmacological considerations in human immunodeficiency virus-infected adults in the intensive care unit. 
  • Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants. 
  • Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402. 
  • Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. 
  • Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. 
  • Pneumocystis carinii pneumonia. 
  • Polyclonal polymorphic B-cell lymphoproliferative disorder with prominent pulmonary involvement in children with acquired immune deficiency syndrome. 
  • Polymerase chain reaction amplification and in situ hybridization for the detection of human B-lymphotropic virus. 
  • Post-dural puncture headache and epidural blood patch in an AIDS patient. 
  • Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. 
  • Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. 
  • Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort. 
  • Predictors of mortality in treatment experienced HIV-infected patients in northern Tanzania. 
  • Predictors of relapse in sexual practices among homosexual men. 
  • Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine. 
  • Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients. 
  • Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. 
  • Process evaluation of the Intervention with Microfinance for AIDS and Gender Equity (IMAGE) in rural South Africa. 
  • Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. 
  • Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy. 
  • Progress in the understanding of HIV infection: an overview. 
  • Progress in vaccines against AIDS. 
  • Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. 
  • Prospects for prevention of and early intervention against HIV. 
  • Prospects for treatment of human retrovirus-associated diseases. 
  • Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. 
  • Psychological discomfort and mental illness in patients with AIDS: implications for home care. 
  • Public Health, HIV Care and Prevention, Human Rights and Democracy at a Crossroad in Brazil. 
  • Pulmonary cysts associated with Pneumocystis carinii pneumonia in patients with AIDS. 
  • Pulmonary cytology of the acquired immune deficiency syndrome: an analysis of 36 cases. 
  • Pulmonary disease in children with AIDS. 
  • Pulmonary toxoplasmosis in AIDS. 
  • Pulmonary tuberculosis in patients with acquired immunodeficiency syndrome. 
  • Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. 
  • Radiologic imaging of AIDS. 
  • Rahnella aquatilis, an unusual gram-negative rod isolated from the bronchial washing of a patient with acquired immunodeficiency syndrome. 
  • Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. 
  • Recent trends in US mortality in early and middle adulthood: racial/ethnic disparities in inter-cohort patterns. 
  • Reduced cardiac selenium content in the acquired immunodeficiency syndrome. 
  • Relation of lifetime trauma and depressive symptoms to mortality in HIV. 
  • Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. 
  • Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange. 
  • Responding to AIDS, tuberculosis, malaria, and emerging infectious diseases in Burma: dilemmas of policy and practice. 
  • Retinal dysfunction as an initial ophthalmic sign in AIDS. 
  • Retinal manifestations of the acquired immune deficiency syndrome (AIDS): cytomegalovirus, candida albicans, cryptococcus, toxoplasmosis and Pneumocystis carinii. 
  • Retrospective. Norman L. Letvin (1949-2012). 
  • Returning home: reflections on the USA's response to the HIV/AIDS epidemic. 
  • Revitalizing HIV Prevention Programs: Recommendations From Those Most Impacted by HIV in the Deep South. 
  • Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. 
  • Right to die issue raises complicated ethical questions. 
  • Risk of infection of health-care workers by human immunodeficiency virus. 
  • Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome. 
  • Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. 
  • Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases. 
  • Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group. 
  • Same-sex behavior, sexually transmitted diseases and HIV risks among young northern Thai men. 
  • Scientific and social issues of human immunodeficiency virus vaccine development. 
  • Screening indices for cytomegalovirus retinitis in patients with human immunodeficiency virus. 
  • Search for the origin of HIV and AIDS. 
  • Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro. 
  • Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. 
  • Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania. 
  • Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome. 
  • Sexual Mixing in Shanghai: Are Heterosexual Contact Patterns Compatible With an HIV/AIDS Epidemic? 
  • Sexually transmitted ocular disorders associated with male homosexuality. 
  • Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. 
  • Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV. 
  • Simultaneous pneumococcal and Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. 
  • Skin manifestations of HIV-1 infection in children. 
  • Slowing the spread of HIV: agenda for the 1990s. 
  • Spontaneous pneumothorax in AIDS patients with Pneumocystis carinii pneumonia. 
  • Structural and functional features of the HIV envelope glycoprotein and considerations for vaccine development. 
  • Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap. 
  • Success hinges on support for treatment. 
  • Suppressor function of T lymphocytes in the acquired immunodeficiency syndrome as assessed by allogeneic mixed lymphocyte culture. 
  • Systemic antiviral drugs used in ophthalmology. 
  • Taste and smell losses in HIV infected patients. 
  • Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk. 
  • The AIDS epidemic: lessons learned? 
  • The HIV-AIDS pandemic at 25--the global response. 
  • The HIV/AIDS epidemic among young people in China between 2005 and 2012: results of a spatial temporal analysis. 
  • The Mid-Atlantic Centers for AIDS Research Consortium: Promoting HIV Science Through Regional Collaboration. 
  • The President's Emergency Plan for AIDS Relief: from successes of the emergency response to challenges of sustainable action. 
  • The ability of certain SIV vaccines to provoke reactions against normal cells. 
  • The acquired immunodeficiency syndrome in intravenous drug abusers and patients with a sexual risk: clinical and postmortem comparisons. 
  • The chest film in the acquired immunodeficiency syndrome. 
  • The chest radiograph in acquired immunodeficiency syndrome. 
  • The crack cocaine problem. A warning from North America. 
  • The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. 
  • The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. 
  • The effect of zidovudine on patient subgroups. 
  • The efficacy of an HIV risk reduction intervention for Hispanic women. 
  • The evolution of virus diseases: their emergence, epidemicity, and control. 
  • The gelatinous bone marrow (serous atrophy) in patients with acquired immunodeficiency syndrome. Evidence of excess sulfated glycosaminoglycan. 
  • The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. 
  • The impacts of donor transitions on health systems in middle-income countries: a scoping review. 
  • The inhibition of human adrenal steroidogenic enzyme activities by suramin. 
  • The management of meatal obstruction due to Kaposi's sarcoma of the glans penis. 
  • The molecular epidemiology of HIV-1 among male sex workers in northern Thailand. 
  • The natural history of HIV-1 infection in young Thai men after seroconversion. 
  • The persistent and evolving HIV epidemic in American men who have sex with men. 
  • The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine. 
  • The psychological well-being of people living with HIV/AIDS and the role of religious coping and social support. 
  • The retinal lesions of the acquired immune deficiency syndrome. 
  • The right to privacy and the duty to protect. 
  • The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. 
  • The science of Durban, AIDS 2016. 
  • The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. 
  • Thymic function, aging, and AIDS. 
  • Timing the ancestor of the HIV-1 pandemic strains. 
  • To help the sick: an historical and ethical essay concerning the refusal to care for patients with AIDS. 
  • Toward a vaccine against AIDS: rationale and current progress. 
  • Toward an understanding of the correlates of protective immunity to HIV infection. 
  • Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. 
  • Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. 
  • Transmission of human immunodeficiency virus to sexual partners of hemophiliacs. 
  • Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. 
  • Treatment of children symptomatic with human immunodeficiency virus infection. 
  • Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. 
  • Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children. 
  • Trends in healthcare expenditure among people living with HIV/AIDS in the United States: evidence from 10 Years of nationally representative data. 
  • Tuberculous abscess of the testicle in AIDS: sonographic demonstration. 
  • Twenty years of AIDS, and no end in sight. A BMJ theme issue will refocus attention on this catastrophic epidemic. 
  • Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. 
  • US trade action threatens Brazilian AIDS programme. 
  • Ultrastructure of AIDS lymph nodes. 
  • Understanding Influences on Intention to Use Pre-exposure Prophylaxis (PrEP) Among African American Young Adults. 
  • Unsung hero Robert C. Gallo. 
  • Use of a brief version of the self-compassion inventory with an international sample of people with HIV/AIDS. 
  • Using Participatory Methods to Assess PrEP Interest and Uptake Among Young People Living in the Southeastern US: A Mixed Methods Assessment. 
  • Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. 
  • Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. 
  • Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. 
  • Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. 
  • Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. 
  • Viral infections in the acquired immunodeficiency syndrome. 
  • Viral particles in the conjunctiva of a patient with the acquired immune deficiency syndrome. 
  • Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A. 
  • Visioning services for children affected by HIV and AIDS through a family lens. 
  • Vulnerable at Each Step in the PMTCT Care Cascade: High Loss to Follow Up During Pregnancy and the Postpartum Period in Tanzania. 
  • Who will enroll? Predicting participation in a phase II AIDS vaccine trial. 
  • Whose priorities? A response to the issue of antiretrovirals in Africa. 
  • Widespread flat warts associated with human papillomavirus type 5: a cutaneous manifestation of human immunodeficiency virus infection. 
  • Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines? 
  • Willingness of nursing students and faculty to care for patients with AIDS. 
  • Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. 
  • You can always pop a pill. 
  • Young Men's Social Network Characteristics and Associations with Sexual Partnership Concurrency in Tanzania. 
  • Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. 
  • Zidovudine and the natural history of AIDS. 
  • Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. 
  • Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study Group. 
  • Zidovudine-induced neutropenia: are we too cautious? 
• 

  Keywords of People

  • Erickson, Harold Paul, James B. Duke Distinguished Professor Emeritus, Cell Biology
  • Klotman, Mary E, R.J. Reynolds Distinguished Professor of Medicine, School of Medicine
  • Muschkin, Clara G., Associate Research Professor Emerita in the Sanford School of Public Policy, Sanford School of Public Policy
  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology
  • Whetten, Kathryn, Professor in the Sanford School of Public Policy, School of Nursing